The Rise of E-cigarette Among Australian High School Students

Jul.18.2024
The Rise of E-cigarette Among Australian High School Students
One-third of Australian high school students use e-cigarettes, with a rise attributed to COVID-19 and easy access.

According to a report by Baotintuc on July 18th, data from the Australian Department of Health shows that on average, one-third of high school students in Australia will use e-cigarettes in the years 2022-2023.


The head of the School of Public Health at the University of Sydney, Associate Professor Becky Freeman, said that in recent years, especially before and after the COVID-19 pandemic, there has been a sharp increase in the proportion of high school students using e-cigarettes as schools close and public health focuses on epidemic control. Disposable high-nicotine e-cigarette products have become extremely popular in Australia.


Freedman believes that one of the reasons for the popularity of e-cigarettes among young people is that these products are marketed as being distinct from traditional cigarettes. In addition, traditional cigarettes are expensive and have health warning images on them, while e-cigarettes do not have these features. Young people perceive e-cigarettes as safe and socially acceptable.


Professor Freeman also pointed out that while the law prohibits the sale of e-cigarettes in retail stores outside of pharmacies, the actual "black market" sales make it easy for teenagers to obtain these products.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Romania Fines Philip Morris and Distributors Over IQOS Price Fixing
Romania Fines Philip Morris and Distributors Over IQOS Price Fixing
Romania’s Competition Council has found that Philip Morris Trading SRL and two distributors engaged in agreements to fix resale prices and promotional discounts for IQOS heated tobacco products.
Dec.19 by 2FIRSTS.ai
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
On January 20, 2026, the U.S. Food and Drug Administration (FDA) posted meeting materials ahead of a virtual Tobacco Products Scientific Advisory Committee (TPSAC) meeting scheduled for January 22, 2026, to discuss modified risk tobacco product (MRTP) applications submitted by Swedish Match USA, Inc. for 20 ZYN nicotine pouch products.
Jan.21 by 2FIRSTS.ai
Product | Airis, Kangvape and HAYATI Launch Christmas-Themed E-cigarettes in UK and US Online Markets
Product | Airis, Kangvape and HAYATI Launch Christmas-Themed E-cigarettes in UK and US Online Markets
As the Christmas holiday season approaches in Europe and North America, e-cigarette brands such as Airis, Kangvape and HAYATI have successively launched Christmas special editions featuring festive-themed designs and selected limited-time flavors, which are now available through online channels in both the United States and the United Kingdom.
Dec.15 by 2FIRSTS.ai
Haypp Report Shows Mint Tops Nicotine Pouch Flavours, Berry Leads Vapes in the UK
Haypp Report Shows Mint Tops Nicotine Pouch Flavours, Berry Leads Vapes in the UK
Online retailer Haypp has released its 2025 Haypp Wrapped report, detailing flavour and brand preferences among UK nicotine pouch and vape users. The report found that mint flavours dominated the nicotine pouch market, while berry flavours were most popular among vape users. Velo and Nordic Spirit led the nicotine pouch category, while Elf Bar and Vuse topped the vape brand rankings.
Dec.24 by 2FIRSTS.ai
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
British American Tobacco’s (BAT) Vuse Ultra vaping product has been listed among winners on the U.S. GOOD DESIGN Awards website, in the “Personal Experience” category, according to the project page. The page identifies the award year as 2025 and names BAT (London) as both the entrant and the manufacturer.
Jan.20 by 2FIRSTS.ai
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai